Latanoprost Ratiopharm Italia

Latanoprost, the active ingredient in Latanoprost Ratiopharm Italia, is a prostaglandin analog presented as a solution for ocular use. It reduces intra‑ocular pressure and is used to treat open‑angle glaucoma and ocular hypertension in adults.

GNH USA supplies Latanoprost Ratiopharm Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used to lower intra‑ocular pressure in glaucoma‑related conditions.

Open‑angle glaucoma: lowers intra‑ocular pressure to slow disease progression. Ocular hypertension: reduces eye pressure to prevent development of glaucoma. Pseudoexfoliative glaucoma: improves aqueous outflow and controls pressure in this secondary open‑angle form.

Latanoprost may cause ocular and peri‑ocular changes, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual brownish pigmentation. - Eye irritation: foreign‑body sensation or mild discomfort. - Blurred vision: transient visual disturbance after instillation. - Periocular skin darkening: mild hyperpigmentation of the eyelid skin.

Serious or Rare Side Effects: - Severe eye inflammation: uveitis or iritis requiring medical attention. - Allergic reaction: swelling, itching, or rash around the eye. - Vision changes: sudden loss of vision or visual field defects. - Ocular infection: signs of bacterial or fungal infection. - Periorbital fat atrophy: noticeable hollowing around the eye. - Corneal edema: swelling of the cornea affecting clarity.

Before using Latanoprost, consider the following safety measures.

Monitor intra‑ocular pressure: ensure adequate pressure reduction. Avoid use in active ocular infection: may exacerbate infection. Caution with uveitis history: can worsen intra‑ocular inflammation. Use carefully in corneal abnormalities: may affect drug absorption. Pregnancy and breastfeeding: safety not established; weigh risks and benefits. Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost can interact with other ocular or systemic agents; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent prostaglandin analogs: additive ocular irritation. - Systemic carbonic anhydrase inhibitors: excessive IOP lowering. - Topical ocular anesthetics: increased corneal toxicity.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce latanoprost efficacy. - Contact lens wear: potential drug adsorption on lenses. - Systemic beta‑blockers: additive systemic hypotensive effect. - Other IOP‑lowering drops: monitor for over‑reduction of pressure.